Hahn & Company and Lutronic CEO Haelyung Hwang Launch Tender Offer to Acquire Lutronic

June 14, 2023

South Korean private equity firm Hahn & Company has signed definitive agreements with Lutronic founder and CEO Haelyung Hwang to jointly launch a tender offer for all remaining shares of Lutronic for KRW957.0 billion (US$735.9 million). Lutronic is a South Korea–based maker of aesthetic medical devices with 2022 revenues of over KRW264 billion and a growing global presence, particularly in the United States and Europe.

Buyers
Hahn & Company, Haelyung Hwang
Targets
Lutronic
Industry
Medical Devices
Location
South Korea
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.